EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS

被引：0
|
作者：
Portolese, Olivia [1 ]
Bilodeau, Marc [2 ]
Castel, Helene [1 ]
Willems, Bernard E. [1 ]
Huard, Genevieve [1 ]
Vincent, Catherine [2 ]
Lavoie, Annick [1 ]
Hercun, Julian [1 ]
机构：
[1] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1708-A
引用
收藏
页码：S638 / S639
页数：2
相关论文
共 50 条
  • [41] Peripheral lung effect of elexacaftor/tezacaftor/ivacaftor in adult cystic fibrosis
    Stylemans, Dimitri
    Darquenne, Chantal
    Schuermans, Daniel
    Verbanck, Sylvia
    Vanderhelst, Eef
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : 160 - 163
  • [42] Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis
    Morgan, Sarah J.
    Nichols, David P.
    Ni, Windy
    Hong, Gina
    Salipante, Stephen J.
    Solomon, George M.
    Rowe, Steven M.
    Clancy, John P.
    Cramer, Robert A.
    Singh, Pradeep K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (09) : 1155 - 1158
  • [43] Elexacaftor/Tezacaftor/Ivacaftor as a Bridge to Lung Retransplant in a Recipient With Cystic Fibrosis
    FitzMaurice, Thomas Simon
    Nazareth, Dilip
    Iyer, Kapil
    Walshaw, Martin
    Al-Aloul, Mohamed
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (04) : 433 - 435
  • [44] Effects of Elexacaftor-Tezacaftor-Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis
    Petit, Guillaume
    Coudert, Aurelie
    Hermann, Ruben
    Truy, Eric
    Bonjour, Maxime
    Reix, Philippe
    Ayari, Sonia
    PEDIATRIC PULMONOLOGY, 2025, 60 (01)
  • [45] Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
    Hernandez, Laura Carrasco
    Moreno, Rosa Ma Giron
    Cartagena, Mari Nieves Balaguer
    Pelaez, Adrian
    Sole, Amparo
    Fernandez, Antonio Alvarez
    Montiel, Almudena Felipe
    Olveira, Casilda
    Olveira, Gabriel
    Bonilla, Ainhoa Gomez
    Crespo, Beatriz Gomez
    Clemente, Marta Garcia
    Garcia, Marta Solis
    Vazquez, Joana Quaresma
    Castro, Enrique Blitz
    Gonzalez, Jesus Rodriguez
    Marrero, Andrea Exposito
    Diab-Caceres, Laila
    Hernandez, Cristina Ramos
    de Lucas, Ester Zamarron
    Sanchez, Concha Prados
    Aparicio, Marina Blanco
    Neyra, Alejandro Lopez
    Santiago, Veronica Sanz
    Paredes, Carmen Luna
    Pecellin, Isabel Delgado
    de la Cruz, Oscar Asensio
    Gallego, Esther Quintana
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (09): : 556 - 565
  • [46] ELEXACAFTOR/TEZACAFTOR/IVACAFTOR CLINICAL EXPERIENCE IN ADULT CYSTIC FIBROSIS PATIENTS
    Finke, J. H.
    Indihar, M.
    Khawar, M.
    Kopras, E.
    Galloway, J.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S226 - S226
  • [47] Disparities in elexacaftor/tezacaftor/ivacaftor initiation in the US cystic fibrosis population
    Jordan, Kamyron
    Vigers, Timothy
    Taylor-Cousar, Jennifer L.
    Sagel, Scott D.
    PEDIATRIC PULMONOLOGY, 2024, 59 (10) : 2681 - 2684
  • [48] Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis
    De Vuyst, Richard C.
    Bennard, Erin
    Kam, Charissa W.
    McKinzie, Cameron J.
    Esther, Charles R.
    PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1592 - 1594
  • [49] Cystic fibrosis: desensitization in delayed hypersensitivity reactions to elexacaftor/tezacaftor/ivacaftor
    Gomez-Ganda, L.
    Galvan-Blasco, P.
    Fernandez-Polo, A.
    Cardona, V.
    Garcia-Palop, B.
    Parramon-Teixido, Cj
    Polverino, E.
    alvarez-Fernandez, A.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [50] Efficacy of Elexacaftor-Tezacaftor-Ivacaftor on chronic rhinosinusitis in cystic fibrosis
    Di Gioia, Stefano
    Lucca, Francesca
    Venditto, Laura
    Sandri, Giulio
    Tommasi, Nicola
    Cipolli, Marco
    Molteni, Gabriele
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (03)
12345